These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
57 related articles for article (PubMed ID: 9194512)
1. Human brain natriuretic peptide reduces blood pressure in normotensive and acute norepinephrine-induced hypertensive rabbits. Clemens LE; Almirez RG; Baudouin KA; Grossbard EB; Protter AA Am J Hypertens; 1997 Jun; 10(6):654-61. PubMed ID: 9194512 [TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics and biological actions of subcutaneously administered human brain natriuretic peptide. Clemens LE; Almirez RG; Baudouin KA; Mischak RP; Grossbard EB; Protter AA J Pharmacol Exp Ther; 1998 Oct; 287(1):67-71. PubMed ID: 9765323 [TBL] [Abstract][Full Text] [Related]
3. Chronic actions of a novel oral B-type natriuretic peptide conjugate in normal dogs and acute actions in angiotensin II-mediated hypertension. Cataliotti A; Chen HH; Schirger JA; Martin FL; Boerrigter G; Costello-Boerrigter LC; James KD; Polowy K; Miller MA; Malkar NB; Bailey KR; Burnett JC Circulation; 2008 Oct; 118(17):1729-36. PubMed ID: 18838565 [TBL] [Abstract][Full Text] [Related]
4. Renal, endocrine, and hemodynamic effects of human brain natriuretic peptide in normal man. Holmes SJ; Espiner EA; Richards AM; Yandle TG; Frampton C J Clin Endocrinol Metab; 1993 Jan; 76(1):91-6. PubMed ID: 8380606 [TBL] [Abstract][Full Text] [Related]
5. Systemic hemodynamic, neurohormonal, and renal effects of a steady-state infusion of human brain natriuretic peptide in patients with hemodynamically decompensated heart failure. Abraham WT; Lowes BD; Ferguson DA; Odom J; Kim JK; Robertson AD; Bristow MR; Schrier RW J Card Fail; 1998 Mar; 4(1):37-44. PubMed ID: 9573502 [TBL] [Abstract][Full Text] [Related]
6. Clearance of human brain natriuretic peptide in rabbits; effect of the kidney, the natriuretic peptide clearance receptor, and peptidase activity. Almirez R; Protter AA J Pharmacol Exp Ther; 1999 May; 289(2):976-80. PubMed ID: 10215677 [TBL] [Abstract][Full Text] [Related]
7. Oral human brain natriuretic peptide activates cyclic guanosine 3',5'-monophosphate and decreases mean arterial pressure. Cataliotti A; Schirger JA; Martin FL; Chen HH; McKie PM; Boerrigter G; Costello-Boerrigter LC; Harty G; Heublein DM; Sandberg SM; James KD; Miller MA; Malkar NB; Polowy K; Burnett JC Circulation; 2005 Aug; 112(6):836-40. PubMed ID: 16061734 [TBL] [Abstract][Full Text] [Related]
8. Examination of the in vivo cardiac electrophysiological effects of nesiritide (human brain natriuretic peptide) in conscious dogs. Fenelon G; Protter AA; Stambler BS J Card Fail; 2002 Oct; 8(5):320-5. PubMed ID: 12411983 [TBL] [Abstract][Full Text] [Related]
9. Effect of haemodialysis on plasma levels of brain natriuretic peptide in patients with chronic renal failure. Lang CC; Choy AM; Henderson IS; Coutie WJ; Struthers AD Clin Sci (Lond); 1992 Feb; 82(2):127-31. PubMed ID: 1311649 [TBL] [Abstract][Full Text] [Related]
10. Characterization of immunoreactive brain natriuretic peptide in human cardiac atrium. Tateyama H; Hino J; Minamino N; Kangawa K; Ogihara T; Matsuo H Biochem Biophys Res Commun; 1990 Feb; 166(3):1080-7. PubMed ID: 2306229 [TBL] [Abstract][Full Text] [Related]
11. Renal sympathetic denervation attenuates hypertension and vascular remodeling in renovascular hypertensive rats. Li P; Huang PP; Yang Y; Liu C; Lu Y; Wang F; Sun W; Kong XQ J Appl Physiol (1985); 2017 Jan; 122(1):121-129. PubMed ID: 27742806 [TBL] [Abstract][Full Text] [Related]
12. [Studies on plasma immunoreactive human brain natriuretic peptide (hBNP) levels in patients with congestive heart failure and present forms of hBNP in human cardiac ventricle]. Togashi K; Kameya T; Ando K; Marumo F; Kawakami M Rinsho Byori; 1991 Jul; 39(7):781-5. PubMed ID: 1920871 [TBL] [Abstract][Full Text] [Related]